Ian Ingram

The FDA approved niraparib and abiraterone acetate (Akeega) in combination with prednisone for treating BRCA2 -mutated metastatic castration-sensitive prostate cancer (mCSPC), the agency announced on Friday. The once-daily, fixed-dose pill, which combines... See more

ORLANDO -- A year of combination therapy for previously untreated chronic lymphocytic leukemia (CLL) patients led to similar outcomes compared with indefinite BTK inhibition with ibrutinib (Imbruvica) alone, an interim analysis of a phase III trial showed... See more

The FDA approved perioperative durvalumab (Imfinzi) in combination with a multidrug chemotherapy regimen for resectable gastric or gastroesophageal junction cancer, the agency announced on Tuesday. Approval stipulates use of the PD-L1 inhibitor in the neo... See more

While guideline-concordant post-polypectomy colonoscopy surveillance was associated with a reduced risk of incident colorectal cancer (CRC) in a large analysis of U.S. veterans, the study found no reduction in risk for fatal CRCs. ( Clinical Gastroenterol... See more

In a nationwide cohort study of Swedes with inflammatory bowel disease (IBD), histologic inflammation and clinically active disease were each associated with higher all-cause mortality at 2 years. ( Clinical Gastroenterology and Hepatology ) Initial surgi... See more